Ondine Biomedical Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar '26 Mar 4, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	53	36	20	40	108	-
Market Cap Growth	9.21%	79.20%	-50.26%	-63.06%	-	-
Enterprise Value	51	35	18	27	127	-
Last Close Price	0.10	0.09	0.09	0.20	0.56	-
PS Ratio	45.17	31.26	27.74	101.96	72.03	-
PB Ratio	137.06	9.31	16.01	5.59	6.24	-
P/TBV Ratio	137.06	9.31	16.01	5.59	6.24	-
EV/Sales Ratio	42.89	30.82	24.90	69.74	84.97	-
Debt / Equity Ratio	0.76	0.02	0.26	0.12	0.02	-1.04
Net Debt / Equity Ratio	-6.90	-1.40	-1.17	-1.01	-1.00	-1.02
Net Debt / EBITDA Ratio	0.21	0.50	0.17	0.63	1.72	-2.31
Net Debt / FCF Ratio	0.27	0.62	0.18	0.71	2.35	-5.41
Asset Turnover	0.35	0.22	0.11	0.03	0.14	-
Inventory Turnover	0.58	0.62	0.42	0.30	1.80	-
Quick Ratio	0.76	1.73	0.95	3.41	7.81	0.03
Current Ratio	0.97	2.05	1.36	3.87	8.54	0.05
Return on Equity (ROE)	-6414.76%	-426.20%	-209.95%	-93.81%	-	-
Return on Assets (ROA)	-235.98%	-130.98%	-82.98%	-46.25%	-59.55%	-
Return on Capital Employed (ROCE)	-2475.30%	-282.70%	-659.80%	-148.20%	-58.00%	47.90%
Earnings Yield	-24.01%	-29.82%	-43.18%	-29.78%	-27.07%	-
FCF Yield	-18.70%	-24.20%	-41.44%	-25.60%	-6.82%	-
Buyback Yield / Dilution	-68.94%	-39.31%	-1.30%	-144.34%	-12.69%	-761.95%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.